INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 101 filers reported holding INHIBRX INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,501,619 | -29.4% | 136,328 | -0.1% | 0.14% | -25.7% |
| Q2 2023 | $3,541,542 | +37.6% | 136,423 | 0.0% | 0.19% | +26.5% |
| Q1 2023 | $2,574,303 | -23.4% | 136,423 | +0.1% | 0.15% | -30.1% |
| Q4 2022 | $3,359,122 | +36.3% | 136,328 | -0.7% | 0.22% | +24.1% |
| Q3 2022 | $2,465,000 | +58.1% | 137,328 | 0.0% | 0.17% | +64.2% |
| Q2 2022 | $1,559,000 | -49.0% | 137,328 | +0.1% | 0.11% | -39.4% |
| Q1 2022 | $3,057,000 | -49.0% | 137,223 | 0.0% | 0.18% | -47.9% |
| Q4 2021 | $5,993,000 | +31.1% | 137,223 | 0.0% | 0.34% | +19.1% |
| Q3 2021 | $4,571,000 | +21.1% | 137,223 | 0.0% | 0.28% | +22.6% |
| Q2 2021 | $3,776,000 | – | 137,223 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,286,435 | $31,697,758 | 8.22% |
| Perceptive Advisors | 3,313,783 | $81,651,613 | 2.29% |
| RA Capital Management | 3,853,867 | $94,959,283 | 1.93% |
| Soleus Capital Management, L.P. | 478,302 | $11,785,361 | 1.69% |
| Sofinnova Investments, Inc. | 1,110,183 | $27,354,909 | 1.62% |
| Birchview Capital, LP | 70,448 | $1,736 | 1.23% |
| VIKING GLOBAL INVESTORS LP | 6,639,199 | $163,589,863 | 0.82% |
| Meridian Wealth Advisors, LLC | 122,315 | $3,013,842 | 0.78% |
| Gyon Technologies Capital Management, LP | 44,074 | $1,085,983 | 0.41% |
| ArrowMark Colorado Holdings LLC | 1,139,337 | $28,073,264 | 0.34% |